Skip to main content

Advertisement

SpringerLink
Log in

The need to monitor emerging issues in etomidate usage: the misuse or abuse potential

  • Review
  • Published:
Forensic Science, Medicine and Pathology Aims and scope Submit manuscript

Abstract

Since 2011, the misuse or abuse of etomidate has gradually increased when propofol was designated a controlled drug under the Narcotics Control Act in Korea. Accordingly, the Ministry of Food and Drug Safety announced that etomidate would be under the ‘Regulation on the designation of drugs that may cause concerns of misuse or abuse’ rule in June 2020, which is less stringent than the Narcotics Control Act. Therefore, this review investigates potential misuse or abuse cases of etomidate to consider strengthening its management. A literature search was conducted to compare etomidate with other sedatives in their efficacy and side effects, as well as identify the adverse health outcomes, abuse cases, and analytical methods of etomidate. Etomidate has an equal or higher sedative efficacy and lower risk of adverse cardiopulmonary events than propofol. However, major adverse effects of etomidate include adrenocortical suppression and unproven associated deaths, as well as myoclonus requiring pre-treatment. Although the issue of abuse and misuse of etomidate is emerging in recent years, there are few academic reports on these issues and analytical methods in the forensic field. In order to effectively manage the misuse or abuse of etomidate, it is necessary to continuously monitor related cases with great interest and to be more intensively studied on its abuse potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

The data used to support the findings of this study are available from the corresponding author upon request.

References

  1. Drugbank Online, Your Guide to Quality Drug Data, Etomidate. Available at: https://go.drugbank.com/drugs/DB00292. Accessed 19 Aug 2021.

  2. Guldner G, Schultz J, Sexton P, Fortner C, Richmond M. Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events. Acad Emerg Med. 2003;10:134–9.

    PubMed  Google Scholar 

  3. Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J. 2004;21:655–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Morris C, McAllister C. Etomidate for emergency anaesthesia; mad, bad and dangerous to know? Anaesthesia. 2005;60:737–40.

    Article  CAS  PubMed  Google Scholar 

  5. Shirley PJ, McAuley DF. Etomidate–misused or misunderstood? Anaesthesia. 2006;61:190.

    Article  CAS  PubMed  Google Scholar 

  6. Zed PJ, Abu-Laban RB, Harrison DW. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med. 2006;13:378–83.

    Article  PubMed  Google Scholar 

  7. Erdoes G, Basciani RM, Eberle B. Etomidate–a review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol Scand. 2014;58:380–9.

    Article  CAS  PubMed  Google Scholar 

  8. Supreme Prosecutors’ Office. A drug-crime white paper 2017 Chapter 1. Available at: https://www.spo.go.kr/site/spo/ex/board/List.do?cbIdx=1204. Accessed 19 Aug 2021.

  9. Jung YK, You SY, Kim SY, Kim JY, Paeng KJ. Simultaneous determination of etomidate and its major metabolite, etomidate acid, in urine using dilute and shoot liquid chromatography-tandem mass spectrometry. Molecules. 2019;24:4459.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ministry of Food and Drug Safety. Report on regulatory impact analysis (Regulation on the designation of drugs that may cause concerns of misuse or abuse). Available at: https://www.mfds.go.kr/brd/m_209/view.do?seq=43304&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=2. Accessed 19 Aug 2021.

  11. Kim MG, Park SW, Kim JH, et al. Etomidate versus propofol sedation for complex upper endoscopic procedures: a prospective double-blinded randomized controlled trial. Gastrointest Endosc. 2017;86:452–61.

    Article  PubMed  Google Scholar 

  12. Park CH, Park SW, Hyun B, et al. Efficacy and safety of etomidate-based sedation compared with propofol-based sedation during ERCP in low-risk patients: a double-blind, randomized, noninferiority trial. Gastrointest Endosc. 2018;87:174–84.

    Article  PubMed  Google Scholar 

  13. Han E, Jung S, Baeck S, Lee S, Chung H. Deaths from recreational use of propofol in Korea. Forensic Sci Int. 2013;233:333–7.

    Article  CAS  PubMed  Google Scholar 

  14. Korean Association Against Drug Abuse. Press release. Available at: https://papago.naver.net/website?locale=ko&source=ko&target=en&url=http%3A%2F%2Fantidrug.drugfree.or.kr%2Fpage%2F%3FmIdx%3D194%26pIdx%3D%26field%3Dtitle%26keyword%3D%25EC%2597%2590%25ED%2586%25A0%25EB%25AF%25B8%25EB%258D%25B0%25EC%259D%25B4%25ED%258A%25B8. Accessed 19 Aug 2021.

  15. Lee JM, Min GH, Keum B, et al. Using etomidate and midazolam for screening colonoscopies results in more stable hemodynamic responses in patients of all ages. Gut Liver. 2019;13:649–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fuchs-Buder T, Sparr HJ, Ziegenfuß T. Thiopental or etomidate for rapid sequence induction with rocuronium? Br J Anaesth. 1998;80:504–6.

    Article  CAS  PubMed  Google Scholar 

  17. Singh PM, Arora S, Borle A, Varma P, Trikha A, Goudra BG. Evaluation of etomidate for seizure duration in electroconvulsive therapy: a systematic review and meta-analysis. J ECT. 2015;31:213–25.

    Article  CAS  PubMed  Google Scholar 

  18. Khalid N, Atkins M, Kirov G. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT. 2006;22:184–8.

    Article  CAS  PubMed  Google Scholar 

  19. Aggarwal S, Goyal VK, Chaturvedi SK, Mathur V, Baj B, Kumar A. A comparative study between propofol and etomidate in patients under general anesthesia. Braz J Anesthesiol. 2016;66:237–41.

    Article  PubMed  Google Scholar 

  20. St. Pierre M, Dunkel M, Rutherford A, Hering W. Does etomidate increase postoperative nausea? A double-blind controlled comparison of etomidate in lipid emulsion with propofol for balanced anaesthesia. Eur J Anaesth. 2000;17:634–641.

  21. Crozier TA, Beck D, Schlaeger M, Wuttke W, Kettler D. Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anesthesiology. 1987;66:628–35.

    Article  CAS  PubMed  Google Scholar 

  22. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia. 1999;54:861–7.

    Article  CAS  PubMed  Google Scholar 

  23. Komatsu R, You J, Mascha EJ, Sessler DI, Kasuya Y, Turan A. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg. 2013;117:1329–37.

    Article  CAS  PubMed  Google Scholar 

  24. Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia. 1984;39:973–81.

    Article  CAS  PubMed  Google Scholar 

  25. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet. 1983;321:1270.

    Article  Google Scholar 

  26. Zhu Y, Yang Y, Zhou C, Bao Z. Using dezocine to prevent etomidate-induced myoclonus: a meta-analysis of randomized trials. Drug Des Dev Ther. 2017;11:2163–70.

    Article  CAS  Google Scholar 

  27. Sunshine JE, Deem S, Weiss NS, et al. Etomidate, adrenal function, and mortality in critically ill patients. Respir Care. 2013;58:639–46.

    Article  PubMed  Google Scholar 

  28. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. The Lancet. 1983;1:1270.

    Article  CAS  Google Scholar 

  29. Williams LM, Boyd KL, Fitzgerald BM. Etomidate. Treasure Island(FL): StatPearls Publishing. 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK535364/?report=reader

  30. McPhee LC, Badawi O, Fraser GL, et al. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. Crit Care Med. 2013;41:774–83.

    Article  CAS  PubMed  Google Scholar 

  31. Freund Y, Jabre P, Mourad J, et al. Relative adrenal insufficiency in critically ill patient after rapid sequence intubation: KETASED ancillary study. J Crit Care. 2014;29:386–9.

    Article  PubMed  Google Scholar 

  32. Gu WJ, Wang F, Tang L, Liu JC. Single-dose etomidate does not increase mortality in patients with sepsis: systematic review and meta-analysis of randomized controlled trials and observational studies. Chest. 2015;147:335–46.

    Article  PubMed  Google Scholar 

  33. Du X, Zhou C, Pan L, Li C. Effect of dexmedetomidine in preventing etomidate-induced myoclonus: a meta-analysis. Drug Des Dev Ther. 2017;11:365–70.

    Article  CAS  Google Scholar 

  34. Wu GN, Xu HJ, Liu FF, Wu X, Zhou H. Low-dose ketamine pretreatment reduces the incidence and severity of myoclonus induced by etomidate: a randomized, double-blinded, controlled clinical trial. Medicine (Baltimore). 2016;95:e2701.

    Article  CAS  PubMed  Google Scholar 

  35. Zhou C, Zhu Y, Liu Z, Ruan L. Effect of pretreatment with midazolam on etomidate-induced myoclonus: a meta-analysis. J Int Med Res. 2017;45:399–406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. An X, Li C, Sahebally Z, Wen X, Zhao B, Fang X. Pretreatment with oxycodone simultaneously reduces etomidate-induced myoclonus and rocuronium-induced withdrawal movements during rapid sequence induction. Med Sci Monit. 2017;23:4989–94.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Liu J, Liu R, Meng C, et al. Propofol decreases etomidate-related myoclonus in gastroscopy. Medicine (Baltimore). 2017;96:e7212.

    Article  CAS  PubMed  Google Scholar 

  38. Zapantis A, Leung S. Tolerance and withdrawal issues with sedation. Crit Care Nurs Clin N Am. 2005;17:211–23.

    Article  Google Scholar 

  39. Valk BI, Struys MM. Etomidate and its analogs: a review of pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2021;60:1253–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. eHealthMe. Etomidate and drug abuse - a phase IV clinical study of FDA data. Available at: https://www.ehealthme.com/ds/etomidate/drug-abuse/. Accessed 5 June 2022.

  41. Eaton N. Medic switched drugs. The Spokesman-Review. Available at: https://www.spokesman.com/stories/2007/jul/06/medic-switched-drugs/. Accessed 19 Aug 2021.

  42. Bryson EO. Chapter 10, The abuse of agents used to induce or maintain general anesthesia: intravenous hypnotics and the halogenated hydrocarbons. Substance abuse: inpatient and outpatient management for every clinician. New York: Springer 2014;115.

  43. Korea Institute of Criminology. Current status and control policies of crimes related to new psychoactive substances 2017. Available at: https://www.kicj.re.kr/board.es?mid=a20201000000&bid=0029&list_no=12441&act=view. Accessed 19 Aug 2021.

  44. Yum H, Jeong S, Jang M, et al. Fast and reliable analysis of veterinary metomidate and etomidate in human blood samples by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a postmortem case. J Forensic Sci. 2021;66:2532–8.

    Article  CAS  PubMed  Google Scholar 

  45. Jeong H. Hankyoreh. Available at: https://www.hani.co.kr/arti/culture/culture_general/1001697.html. Accessed 5 June 2022.

  46. Song S. News1. Available at: https://www.news1.kr/articles/?4635472. Accessed 5 June 2022.

  47. Torralva KM. Dallasnews. Allen brewer’s federal fraud trial centers on mysterious death of Carrollton man. Available at: https://www.dallasnews.com/news/courts/2022/09/29/allen-brewers-federal-fraud-trial-centers-on-mysterious-death-of-carrollton-man/. Accessed 5 Jan 2023.

  48. Dziemianowicz J. Oxygen. ‘He Wasn’t Dying Quick Enough’: Nurse Kills Heart Surgeon Husband To Obtain His Wealth. Available at: https://www.oxygen.com/accident-suicide-or-murder/crime-news/dr-david-stephens-given-drug-overdose-by-wife-stephanie. Accessed 5 June 2022.

  49. Molina DK, Hargrove VM, Rodriguez RG. Distribution of etomidate in a fatal intoxication. J Anal Toxicol. 2008;32:715–8.

    Article  CAS  PubMed  Google Scholar 

  50. Avram MJ, Fragen RJ, Linde HW. High-performance liquid chromatographic assay for etomidate in human plasma: results of preliminary clinical studies using etomidate for hypnosis in total intravenous anesthesia. J Pharm Sci. 1983;72:1424–6.

    Article  CAS  PubMed  Google Scholar 

  51. Le Moing JP, Levron JC. High-performance liquid chromatographic determination of etomidate in plasma. J Chromatogr. 1990;529:217–22.

    Article  PubMed  Google Scholar 

  52. Ellis EO, Beck PR. Determination of etomidate in human plasma by high-performance liquid chromatography. J Chromatogr. 1982;232:207–11.

    Article  CAS  PubMed  Google Scholar 

  53. Haring CM, Dijkhuis IC, Van Dijk B. A rapid method of determining serum levels of etomidate by gas chromatography with the aid of a nitrogen detector. Acta Anaesthesiol Belg. 1980;31:107–12.

    CAS  PubMed  Google Scholar 

  54. De Boer AG, Smeekens JB, Breimer DD. Assay of etomidate in plasma by capillary gas chromatography with nitrogen-selective detection. J Chromatogr. 1979;162:591–5.

    Article  PubMed  Google Scholar 

  55. Van Hamme MJ, Ambre JJ, Ghoneim MM. Mass fragmentographic determination of plasma etomidate concentrations. J Pharm Sci. 1977;66:1344–6.

    Article  PubMed  Google Scholar 

  56. Luhmann I, Szathmary SC. Sensitive and automated gas chromatographic method for the determination of etomidate in plasma samples. J Chromatogr. 1990;532:150–4.

    Article  CAS  PubMed  Google Scholar 

  57. Remane D, Montenarh D, Meyer MR, Maurer HH. Application of a UHPLC MS/MS-based multianalyte approach for screening and validated quantification of drugs in human blood plasma often requested in the context of brain death diagnosis. Ther Drug Monit. 2014;36:257–60.

    Article  CAS  PubMed  Google Scholar 

  58. Park YJ, Cho E, Kim SH, et al. Determination of etomidate and etomidate acid in hair using liquid chromatography–tandem mass spectrometry. J forensic Sci. 2022;67:2479–86.

    Article  CAS  PubMed  Google Scholar 

  59. Fragen RJ, Shanks CA, Molteni A. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology. 1984;61:652–6.

    Article  CAS  PubMed  Google Scholar 

  60. Duthie DJR, Fraser R, Nimmo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth. 1985;57:156–9.

    Article  CAS  PubMed  Google Scholar 

  61. Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology. 2011;114:695–707.

    Article  CAS  PubMed  Google Scholar 

  62. Wagner RL, White PF. Etomidate inhibits adrenocortical function in surgical patients. Anesthesiology. 1984;61:647–51.

    Article  CAS  PubMed  Google Scholar 

  63. Price K, Allen U, Mandersloot G, Shirley P, McAuley D. Effect of a single dose of etomidate on adrenal function in patients with trauma. Crit Care. 2005;9:P392.

    Article  PubMed Central  Google Scholar 

  64. Ruth WJ, Burton JH, Bock AJ. Intravenous etomidate for procedural sedation in emergency department patients. Acad Emerg Med. 2001;8:13–8.

    Article  CAS  PubMed  Google Scholar 

  65. Drugs.com. Etomidate. Available at: https://www.drugs.com/cdi/etomidate.html. Accessed 31 Jan 2023.

Download references

Funding

This research was supported by the Duksung Women’s University Research Grants 2020 (3000005401), Korea.

Author information

Authors and Affiliations

  1. College of Pharmacy, Duksung Women’s University, Seoul, South Korea

    Jiyeong Uhm, Songhee Hong & Eunyoung Han

Authors
  1. Jiyeong Uhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Songhee Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eunyoung Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eunyoung Han.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jiyeong Uhm and Songhee Hong contributed equally to this work.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uhm, J., Hong, S. & Han, E. The need to monitor emerging issues in etomidate usage: the misuse or abuse potential. Forensic Sci Med Pathol 20, 249–260 (2024). https://doi.org/10.1007/s12024-023-00596-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12024-023-00596-4

Keywords

Search

Navigation